BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

916 related articles for article (PubMed ID: 32902367)

  • 1. Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.
    Montenegro F; Unigarro L; Paredes G; Moya T; Romero A; Torres L; López JC; González FEJ; Del Pozo G; López-Cortés A; Diaz AM; Vasconez E; Cevallos-Robalino D; Lister A; Ortiz-Prado E
    Expert Rev Respir Med; 2021 Feb; 15(2):183-195. PubMed ID: 32902367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventilation management in acute respiratory failure related to COVID-19 versus ARDS from another origin - a descriptive narrative review.
    Tsonas AM; Botta M; Serpa Neto A; Horn J; Paulus F; Schultz MJ
    Expert Rev Respir Med; 2021 Aug; 15(8):1013-1023. PubMed ID: 33847219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.
    Harrell CR; Jovicic BP; Djonov V; Volarevic V
    Anal Cell Pathol (Amst); 2020; 2020():1939768. PubMed ID: 33274176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization.
    Caravita S; Baratto C; Di Marco F; Calabrese A; Balestrieri G; Russo F; Faini A; Soranna D; Perego GB; Badano LP; Grazioli L; Lorini FL; Parati G; Senni M
    Eur J Heart Fail; 2020 Dec; 22(12):2228-2237. PubMed ID: 33200458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
    Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
    Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical ventilation in COVID-19: A physiological perspective.
    Cronin JN; Camporota L; Formenti F
    Exp Physiol; 2022 Jul; 107(7):683-693. PubMed ID: 34541721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Guven BB; Erturk T; Kompe Ö; Ersoy A
    Epidemiol Infect; 2021 Jun; 149():e137. PubMed ID: 34099076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
    Gando S; Wada T
    Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
    Pan C; Xie JF; Qiu HB; Yang Y
    Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.
    Xia J; Feng Y; Li M; Yu X; Zhang Y; Duan J; Zhan Q
    BMC Infect Dis; 2020 Aug; 20(1):637. PubMed ID: 32854630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis.
    Dmytriw AA; Chibbar R; Chen PPY; Traynor MD; Kim DW; Bruno FP; Cheung CC; Pareek A; Chou ACC; Graham J; Dibas M; Paranjape G; Reierson NL; Kamrowski S; Rozowsky J; Barrett A; Schmidt M; Shahani D; Cowie K; Davis AR; Abdelmegeed M; Touchette JC; Kallmes KM; Pederson JM; Keesari PR
    Expert Rev Respir Med; 2021 Oct; 15(10):1347-1354. PubMed ID: 33882768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.
    Rajdev K; Farr LA; Saeed MA; Hooten R; Baus J; Boer B
    J Investig Med High Impact Case Rep; 2020; 8():2324709620957778. PubMed ID: 32911986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic.
    Panwar R; Madotto F; Laffey JG; van Haren FMP
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1244-1252. PubMed ID: 32805143
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
    Lupu L; Palmer A; Huber-Lang M
    Front Immunol; 2020; 11():584514. PubMed ID: 33101314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute respiratory failure in the course of COVID-19. Practical hints from the expert panel of the Assembly of Intensive Care and Rehabilitation of the Polish Respiratory Society.
    Czajkowska-Malinowska M; Kania A; Kuca PJ; Nasiłowski J; Skoczyński S; Sokołowski R; Śliwiński PS
    Adv Respir Med; 2020; 88(3):245-266. PubMed ID: 32706108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
    Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
    Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages.
    Ammar MA; Sacha GL; Welch SC; Bass SN; Kane-Gill SL; Duggal A; Ammar AA
    J Intensive Care Med; 2021 Feb; 36(2):157-174. PubMed ID: 32844730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
    Gorman E; Millar J; McAuley D; O'Kane C
    Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 46.